Pnd104 - Recommendations for a National Multiple Sclerosis (Ms) Strategy

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment Recommendations for Interferon-Beta in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1999English

Recommendations for Cognitive Screening and Management in Multiple Sclerosis Care

Multiple Sclerosis
Neurology
2018English

Novel Remyelination Strategy for Multiple Sclerosis in the Era of Oligodendrocytopathy

Clinical Neurology
Neurology
2012English

Ultraviolet Radiation (UVR) and Risk of Developing Multiple Sclerosis (MS)

Canadian Journal of Neurological Sciences
MedicineNeurology
2011English

In Vitro Screen for Small Molecules to Promote Myelin Repair in Multiple Sclerosis (MS)

Science-Business eXchange
2014English

Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review With Recommendations for Future Research

Neural Plasticity
Neurology
2019English

Cyclophosphamide in Exacerbations of Multiple Sclerosis. Therapeutic Trial and a Strategy for Pilot Drug Studies.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1975English

Current Multiple Sclerosis Treatments Have Improved Our Understanding of MS Autoimmune Pathogenesis

European Journal of Immunology
AllergyImmunology
2016English

Biotin for Multiple Sclerosis

Pharmacy Today
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy